ATE305934T1 - Verfahren zur herstellung von maytansinol - Google Patents

Verfahren zur herstellung von maytansinol

Info

Publication number
ATE305934T1
ATE305934T1 AT02726608T AT02726608T ATE305934T1 AT E305934 T1 ATE305934 T1 AT E305934T1 AT 02726608 T AT02726608 T AT 02726608T AT 02726608 T AT02726608 T AT 02726608T AT E305934 T1 ATE305934 T1 AT E305934T1
Authority
AT
Austria
Prior art keywords
maytansinol
producing
preparing
producing maytansinol
unreduced
Prior art date
Application number
AT02726608T
Other languages
English (en)
Inventor
Gerald J Terfloth
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE305934T1 publication Critical patent/ATE305934T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02726608T 2001-03-16 2002-03-12 Verfahren zur herstellung von maytansinol ATE305934T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27679201P 2001-03-16 2001-03-16
PCT/US2002/007424 WO2002074775A1 (en) 2001-03-16 2002-03-12 Process for preparing maytansinol

Publications (1)

Publication Number Publication Date
ATE305934T1 true ATE305934T1 (de) 2005-10-15

Family

ID=23058083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726608T ATE305934T1 (de) 2001-03-16 2002-03-12 Verfahren zur herstellung von maytansinol

Country Status (7)

Country Link
US (2) US20020156274A1 (de)
EP (1) EP1373273B1 (de)
JP (1) JP2004526734A (de)
AT (1) ATE305934T1 (de)
DE (1) DE60206477T2 (de)
ES (1) ES2248550T3 (de)
WO (1) WO2002074775A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US7589180B2 (en) 2001-05-11 2009-09-15 Abbott Laboratories Inc. Specific binding proteins and uses thereof
AU2003228998A1 (en) * 2002-05-13 2003-12-02 Smithkline Beecham Corporation Process for preparing maytansinol
WO2004015119A2 (en) * 2002-08-08 2004-02-19 Smithkline Beecham Corporation Methods for the isolation and purification of ansamitocins
US7432088B2 (en) * 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
EP3381446A1 (de) * 2004-10-29 2018-10-03 The Regents of The University of California Poröse photonische kristalle zur verabreichung von wirkstoffen ins auge
US20070135629A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
EP2126127B1 (de) 2007-01-25 2016-09-28 Dana-Farber Cancer Institute, Inc. Verwendung von anti-egfr-antikörpern bei der behandlung von durch egfr-mutanten vermittelten krankheiten
CA2680854C (en) 2007-03-15 2017-02-14 Ludwig Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
US9283276B2 (en) 2007-08-14 2016-03-15 Ludwig Institute For Cancer Research Ltd. Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
US9173961B2 (en) 2010-02-10 2015-11-03 Immunogen, Inc. CD20 antibodies and uses thereof
CN103604803B (zh) * 2013-11-11 2015-11-25 深圳大学 一种快速检测红酒中铁离子含量的方法
JP6894423B2 (ja) 2015-07-09 2021-06-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 融合性リポソーム被覆多孔質ケイ素ナノ粒子
CN113825759B (zh) * 2019-03-01 2024-06-04 细胞基因公司 美登醇的制备
JP7772363B2 (ja) 2019-11-29 2025-11-18 日本マイクロバイオファーマ株式会社 メイタンシノールの酵素的生産方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) * 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
CA2006408A1 (en) * 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US6333410B1 (en) * 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents

Also Published As

Publication number Publication date
JP2004526734A (ja) 2004-09-02
EP1373273B1 (de) 2005-10-05
ES2248550T3 (es) 2006-03-16
US20020156274A1 (en) 2002-10-24
DE60206477T2 (de) 2006-06-22
US20050113571A1 (en) 2005-05-26
WO2002074775A1 (en) 2002-09-26
EP1373273A4 (de) 2004-07-14
EP1373273A1 (de) 2004-01-02
DE60206477D1 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
DE60206477D1 (de) Verfahren zur herstellung von maytansinol
DE4495679T1 (de) Verfahren und Vorrichtung zur Programmerweiterung zellularer mobiler Telefone
EP0655777A3 (de) Varaktor und Verfahren zur Herstellung.
ATE129265T1 (de) Hartschaumstoff sowie verfahren zur herstellung desselben.
DE69103230D1 (de) 1-Pyridylimidazolderivat und Verfahren zur Herstellung und Anwendung.
AT4947U3 (de) Vollnarbiges rindnappaleder und verfahren zur herstellung desselben
ATE169180T1 (de) Verfahren zur herstellung überzogener mikrobieller pestizide und so hergestellte pestizide
ATA152591A (de) Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen
DE60019682D1 (de) Poröse Metallkörper, Verfahren zur Herstellung derselben und diese verwendende Metall-Verbundmaterialien
DE60002286D1 (de) Verfahren zur Herstellung von Ketonen, Alkoholen und Hydroperoxiden
DE60003185D1 (de) Verfahren zur herstellung von kalthärtenden flexiblen schäumen, polyolzusammensetzung und dafür nützliches reaktionssystem, damit erhaltene schäume
DE69708711D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid
DE69701002D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid
DE69616446D1 (de) Verfahren zur herstellung von alpha-haloketonen, alpha-halohydrinen und epoxiden
DE60121150D1 (de) Verfahren zur herstellung von ansamitocin
ATE388135T1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
DE69736286D1 (de) Verfahren zur herstellung und transformation von manioka protoplasten
DE68904582D1 (de) Elektroakoustische membran und verfahren zur herstellung.
DE59106383D1 (de) Verfahren und einrichtung zur oxidation von wasserstoff.
DE60045615D1 (de) Verfahren und gerät zur herstellung von kommunikationsverbindungen
DE69709127D1 (de) Verfahren zur herstellung von iohexol
ATE229077T1 (de) Verfahren zur herstellung von lipstatin und tetrahydrolipstatin
DE69106421D1 (de) Verfahren und Vorrichtung zur Herstellung von Metallpulver.
DE59702009D1 (de) Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan und dessen derivaten
WO2003096782A3 (en) Process for preparing maytansinol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties